Risk of complete atypical femur fracture with Oral bisphosphonate exposure beyond three years

BACKGROUND: Bisphosphonate (BP) therapy has been associated with atypical femur fracture (AFF). However, the threshold of treatment duration leading to increased AFF risk is unclear. In a retrospective cohort of older women initiating BP, we compared the AFF risk associated with treatment for at lea...

Descripción completa

Detalles Bibliográficos
Autores principales: Lo, Joan C., Neugebauer, Romain S., Ettinger, Bruce, Chandra, Malini, Hui, Rita L., Ott, Susan M., Grimsrud, Christopher D., Izano, Monika A.
Formato: Online Artículo Texto
Lenguaje:English
Publicado: BioMed Central 2020
Materias:
Research Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7713036/
https://www.ncbi.nlm.nih.gov/pubmed/33272248
http://dx.doi.org/10.1186/s12891-020-03672-w

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7713036/
https://www.ncbi.nlm.nih.gov/pubmed/33272248
http://dx.doi.org/10.1186/s12891-020-03672-w

Ejemplares similares